Standout Papers

Clinical and immunological features of severe and moderate coronavirus disease 2019 2020 2026 2022 20243.1k
  1. Clinical and immunological features of severe and moderate coronavirus disease 2019 (2020)
    Guang Chen, Di Wu et al. Journal of Clinical Investigation

Immediate Impact

21 from Science/Nature 82 standout
Sub-graph 1 of 18

Citing Papers

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Natural killer cell therapies
2024 StandoutNature
3 intermediate papers

Works of Shiji Wu being referenced

Tim-3 pathway affects NK cell impairment in patients with active tuberculosis
2015
Tim-3 Negatively Mediates Natural Killer Cell Function in LPS-Induced Endotoxic Shock
2014
and 1 more

Author Peers

Author Last Decade Papers Cites
Shiji Wu 3252 542 763 1709 44 4.4k
Wei Guo 2879 564 714 1514 49 4.2k
Luo‐Qi Zhou 3252 566 631 1950 41 5.0k
Hongwu Wang 2558 560 539 1480 37 3.7k
Shusheng Li 2908 559 449 1692 71 4.4k
Meifang Han 2778 1125 722 1558 57 4.7k
Yong Xiong 3066 635 450 1515 68 4.2k
Da Huang 2504 442 460 1446 76 3.9k
Ziwei Hu 3250 424 447 1841 21 4.1k
Ke Ma 3783 617 523 2069 80 5.3k
Tao Wang 2749 478 841 1469 83 5.1k

All Works

Loading papers...

Rankless by CCL
2026